News

FOP is characterized by painful, recurrent episodes of soft tissue swelling (flare-ups) and new abnormal bone formation. The process called heterotopic ossification (HO) occurs in muscles, tendons and

Enhanze is based on a recombinant human hyaluronidase enzyme (rHuPH20) that temporarily modifies hyaluronan, a component of the extracellular matrix, to aid in the dispersion and absorption of

Apotex has been jointly developing the product in collaboration with Intas Pharmaceuticals. The company’s application was filed under the 351(k) abbreviated approval pathway created by the q2Biosimilar Price

The IND covers the company’s clinical development plan for a patented formulation of itraconazole (SUBA-Itraconazole) with improved bioavailability to study the treatment of basal cell carcinoma (BCC) in

As part of the partnership, both the firms will jointly evaluate both clinical and pre-clinical stage projects that will be identified and presented by BioLineRx through a Joint

As part of this collaboration, Ossianix’s new single Blood Brain Barrier (BBB) targeting domain antibody platform that is based on the shark VNAR structure will be used for

The trial is designed to evaluate the safety, tolerability and efficacy of PF-06252616 in boys aged six to less than ten years old diagnosed with DMD regardless of

Pursuant to the agreement Adapt has received from Lightlake a global license to develop and commercialize Lightlake’s intranasal naloxone opioid overdose reversal treatment. In exchange for licensing its

Its lead compound PPL-003 showed success in two studies in rabbits. In the first study, topical eye administration of PPL-003 at the highest feasible dose was well tolerated